| Wednesday, January 19, 2022 |
| 10:00 AM - 11:00 AM Japan Standard Time |
| 09:00 AM - 10:00 AM China Standard Time |
| Tuesday, January 18, 2022 |
| 08:00 PM - 09:00 PM Eastern Standard Time |
| 05:00 PM - 06:00 PM Pacific Standard Time |
In this session, partners Kathleen Sanzo, Jacqueline Berman, Nancy Yamaguchi, and Jitsuro Morishita will explain how the biopharma industry is using AI to increase efficiencies during the drug development process, explore the legal and regulatory implications of AI’s application to clinical trials, and discuss the potential future of AI in the Food and Drug Administration’s drug and biologic divisions.